About 2 results found for searched term "ARCC-4" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10963 | ARCC-4 | Others |
| ARCC-4 is based on PROTAC technology, a nanomolar grade androgen receptor (AR) degrader D50 The value is 5 nM. ARCC-4 is an AR PROTAC recruited by von Hippel-Lindau (VHL) based on enzalutamide. ARCC-4 effectively degrades AR mutations associated with antiandrogen studies. | ||
| M58035 | ARCC 4 negative control | Others |
| ARCC 4 negative control | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
